EL.En. S.p.A. (BIT:ELN)
Italy · Delayed Price · Currency is EUR 11.67
-0.35 (-2.91%)
Jul 31, 2025, 5:35 PM CET
Checkpoint Therapeutics Revenue
EL.En. had revenue of 140.90M EUR in the quarter ending March 31, 2025, with 8.76% growth. This brings the company's revenue in the last twelve months to 577.19M, up 6.06% year-over-year. In the year 2024, EL.En. had annual revenue of 565.85M, down -1.76%.
Revenue (ttm)
577.19M
Revenue Growth
+6.06%
P/S Ratio
1.62
Revenue / Employee
277.50K
Employees
2,080
Market Cap
936.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 565.85M | -10.17M | -1.76% |
| Dec 31, 2023 | 576.01M | -97.57M | -14.49% |
| Dec 31, 2022 | 673.58M | 102.18M | 17.88% |
| Dec 31, 2021 | 571.40M | 163.32M | 40.02% |
| Dec 31, 2020 | 408.08M | 7.32M | 1.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B |
| DiaSorin | 1.21B |
| Amplifon | 2.42B |
| Philogen | 77.65M |
| Safilo Group | 993.22M |
| GPI S.p.A. | 509.93M |
| Garofalo Health Care | 470.20M |
| Pharmanutra | 116.15M |
EL.En. News
- 1 year ago - Buying EL.En.: Laser Artistry From Florence To The World - Seeking Alpha
- 1 year ago - Buying EL.En.: Laser Artistry From Florence To The World - Seeking Alpha